Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease

Annals of Neurology

Volumn 69, Issue 5, 2011, Pages 793-802

  Piallat, Brigitte ^a   Polosan, Mircea ^a,b   Fraix, Valérie ^a,b   Goetz, Laurent ^a   David, Olivier ^a,b   Fenoy, Albert ^a   Torres, Napoleon ^c   Quesada, Jean Louis ^a,b   Seigneuret, Eric ^a,b   Pollak, Pierre ^a,b   Krack, Paul ^a,b   Bougerol, Thierry ^a,b   Benabid, Alim L ^a,c   Chabardès, Stéphan ^a,b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Atomic and Alternative Energies Commission   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BROMAZEPAM; CITALOPRAM; CLOBAZAM; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; CYAMEMAZINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; HYDROXYZINE; LAMOTRIGINE; LEVOMEPROMAZINE; MIANSERIN; PAROXETINE; PIMOZIDE; RISPERIDONE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MALE; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SUBTHALAMIC NUCLEUS;

ACTION POTENTIALS; ADULT; AGED; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; OBSESSIVE-COMPULSIVE DISORDER; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 79955371281     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22222     Document Type: Article

References (53)

1. Stein DJ., Obsessive-compulsive disorder. Lancet 2002; 360: 397-405.
2. Thobois S, Jouanneau E, Bouvard M, Sindou M., Obsessive-compulsive disorder after unilateral caudate nucleus bleeding. Acta Neurochir (Wien) 2004; 146: 1027-1031; discussion 1031. (Pubitemid 39222800)
3. Cheyette SR, Cummings JL., Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci 1995; 7: 125-134.
4. Saxena S, Rauch SL., Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 563-586. (Pubitemid 30666507)
5. Saxena S, Brody AL, Schwartz JM, Baxter LR., Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998; (35): 26-37. (Pubitemid 28368348)
6. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689.
7. Alexander GE, DeLong MR, Strick PL., Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381. (Pubitemid 16055790)
8. Cummings JL., Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873-880. (Pubitemid 23229317)
9. Krack P, Kumar R, Ardouin C, et al. Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 2001; 16: 867-875. (Pubitemid 36041188)
10. Parent A, Hazrati LN., Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995; 20: 128-154.
11. Dougherty DD, Baer L, Cosgrove GR, et al. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry 2002; 159: 269-275. (Pubitemid 34126905)
12. Kihlstrom L, Hindmarsh T, Lax I, et al. Radiosurgical lesions in the normal human brain 17 years after gamma knife capsulotomy. Neurosurgery 1997; 41: 396-401; discussion 401-402.
13. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999; 354: 1526. (Pubitemid 29502111)
14. Greenberg BD, Price LH, Rauch SL, et al. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin North Am 2003; 14: 199-212. (Pubitemid 36514460)
15. Montoya A, Weiss AP, Price BH, et al. Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery 2002; 50: 1043-1049; discussion 1049-1052.
16. Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat 2003; 26: 293-299. (Pubitemid 38077152)
17. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008; 359: 2121-2134.
18. Benabid AL, Chabardes S, Mitrofanis J, Pollak P., Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81.
19. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998; 44: 622-628. (Pubitemid 28477849)
20. Magarinos-Ascone CM, Figueiras-Mendez R, Riva-Meana C, Cordoba-Fernandez A., Subthalamic neuron activity related to tremor and movement in Parkinson's disease. Eur J Neurosci 2000; 12: 2597-2607. (Pubitemid 30497053)
21. Magnin M, Morel A, Jeanmonod D., Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 2000; 96: 549-564. (Pubitemid 30136320)
22. Steigerwald F, Potter M, Herzog J, et al. Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J Neurophysiol 2008; 100: 2515-2524.
23. Bergman H, Wichmann T, Karmon B, DeLong MR., The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994; 72: 507-520.
24. National Consultative Ethics Committee on Health and Life Sciences Opinion on functional neurosurgery for severe psychiatric disorder Number 71 2002-04-25.
25. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006-1011.
26. Benabid AL, Krack PP, Benazzouz A, et al. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 2000; 55: S40-S44. (Pubitemid 32103942)
27. Piallat B, Chabardes S, Torres N, et al. Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience 2009; 158: 1201-1205.
28. Murer MG, Riquelme LA, Tseng KY, Pazo JH., Substantia nigra pars reticulata single unit activity in normal and 60HDA-lesioned rats: effects of intrastriatal apomorphine and subthalamic lesions. Synapse 1997; 27: 278-293. (Pubitemid 27479466)
29. Abeles M., Quantification, smoothing, and confidence limits for single-units' histograms. J Neurosci Methods 1982; 5: 317-325. (Pubitemid 12055858)
30. Morel A., Stereotactic atlas of the human thalamus and basal ganglia. New York, NY: Informa Healthcare USA, 2007.
31. Levy R, Hutchison WD, Lozano AM, Dostrovsky JO., High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 2000; 20: 7766-7775.
32. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001; 124: 1777-1790. (Pubitemid 32845439)
33. Wichmann T, Bergman H, DeLong MR., The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 1994; 72: 494-506.
34. Alexander GE, Crutcher MD, DeLong MR., Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990; 85: 119-146.
35. Parent A, Smith Y., Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res 1987; 436: 296-310. (Pubitemid 18003569)
36. Monakow KH, Akert K, Kunzle H., Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 1978; 33: 395-403. (Pubitemid 9037793)
37. DeLong MR, Crutcher MD, Georgopoulos AP., Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 1985; 53: 530-543. (Pubitemid 15134963)
38. Abeles M., Neuroscience. Time is precious. Science 2004; 304: 523-524.
39. Baxter LR Jr, Schwartz JM, Mazziotta JC, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145: 1560-1563. (Pubitemid 19009706)
40. Molina V, Montz R, Martin-Loeches M, et al. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J Nucl Med 1995; 36: 2234-2238.
41. Nordahl TE, Benkelfat C, Semple WE, et al. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989; 2: 23-28. (Pubitemid 19126156)
42. Simpson S, Baldwin B., Neuropsychiatry and SPECT of an acute obsessive-compulsive syndrome patient. Br J Psychiatry 1995; 166: 390-392.
43. Lacerda AL, Dalgalarrondo P, Caetano D, et al. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res 2003; 123: 125-134. (Pubitemid 36794578)
44. Swedo SE, Schapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46: 518-523. (Pubitemid 19153879)
45. van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009; 132: 853-868.
46. Flor-Henry P., The obsessive-compulsive syndrome: reflection of fronto-caudate dysregulation of the left hemisphere? [in French]. Encephale 1990; 16: 325-329.
47. Guehl D, Benazzouz A, Aouizerate B, et al. Neuronal correlates of obsessions in the caudate nucleus. Biol Psychiatry 2008; 63: 557-562. (Pubitemid 351284469)
48. Zhang QJ, Liu X, Liu J, et al. Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats. Brain Res 2009; 1256: 180-189.
49. Dremencov E, El Mansari M, Blier P., Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J Psychiatry Neurosci 2009; 34: 223-229.
50. Marceglia S, Mrakic-Sposta S, Foffani G, et al. Gender-related differences in the human subthalamic area: a local field potential study. Eur J Neurosci 2006; 24: 3213-3222. (Pubitemid 44952653)
51. Aouizerate B., Pathophysiological bases of obsessive-compulsive disorder and therapeutic implications [in French]. Rev Prat 2007; 57: 59-63. (Pubitemid 46212320)
52. Graybiel AM, Rauch SL., Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000; 28: 343-347.
53. Fontaine D, Mattei V, Borg M, et al. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. J Neurosurg 2004; 100: 1084-1086. (Pubitemid 38661624)